| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 6,210,786 shares worth roughly $120.4M. In the past 30 days, 0 insiders bought and 2 sold.
All 2 insiders who sold still hold shares after their sales. RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 21.90M | $424.96M | - | |
| CEO | 471.3K | $8.53M | -48,199 | |
| Pres | 399.1K | $7.57M | - | |
| Other | 223.7K | $4.48M | - | |
| CFO | 105.1K | $1.95M | -17,717 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 21,664 | $7.29 | $157,930.56 | -6.5% | +0.9% | +141.8% | |
| Oct 28, 2025 | Bergstrom Donald A74 | President, R&D | Sell | 30,897 | $7.29 | $225,239.13 | -5.6% | +0.9% | +141.8% | |
| Jul 29, 2025 | Rahmer Peter61 | See Remarks | Sell | 17,083 | $3.68 | $62,946.98 | -4.3% | +103.9% | +407.5% | |
| Jul 29, 2025 | Catinazzo Thomas69 | Chief Financial Officer | Sell | 20,081 | $3.69 | $74,000.14 | -5.7% | +103.9% | +407.5% | |
| Jul 29, 2025 | Bergstrom Donald A74 | President, R&D | Sell | 30,770 | $3.69 | $113,477.74 | -5.3% | +103.9% | +407.5% | |
| Jul 29, 2025 | Adams Brian71 | Chief Legal Officer | Sell | 19,913 | $3.68 | $73,378.06 | -5.1% | +103.9% | +407.5% | |
| Jul 9, 2025 | Patel Sanjiv73 | President and CEO | Sell | 61,379 | $3.57 | $219,123.03 | -7.4% | +53.0% | +444.6% | |
| Apr 30, 2025 | Catinazzo Thomas69 | Chief Financial Officer | Sell10b5-1 | 19,191 | $3.07 | $58,848.64 | -5.1% | +8.7% | +289.2% | |
| Apr 30, 2025 | Bergstrom Donald A74 | President, R&D | Sell | 31,562 | $3.02 | $95,381.30 | -5.1% | +8.7% | +289.2% | |
| Apr 30, 2025 | Adams Brian71 | Chief Legal Officer | Sell | 14,587 | $3.02 | $44,040.48 | -3.6% | +8.7% | +289.2% |